`ÿÿ !"ÿ #ÿ$%%&ÿÿ
`# "ÿ'ÿ("&ÿ")!ÿ
` ÿ ÿ
`
`
`**************************ÿ
`,-./0ÿ10234ÿ,-./0ÿ-,056,275810.ÿ
`91-17/:4ÿÿ
`;<<=>>?@ABÿ
`ÿÿ
`C3ÿ
`ÿÿ,0:8/1ÿ1,0254ÿ:DEFGHIE4ÿ53J3ÿKLHFMHÿLMNÿ
`7ELNFOLEPÿQRRDGF4ÿÿ
`S@A=TU=@VTÿ
`**************************ÿ
`WXYZ[WY\Yÿ
`**************************ÿ
`] ÿ^
`_ÿ ÿ`
`d^^ eÿb ÿÿ
`
`ÿhbiWXYj[
`XYklWÿÿ
`**************************ÿ
`Qÿ8ÿ:ÿ/ÿ8ÿ
``
`ÿ
`^
`ÿ^
`_ÿ ÿm
`ÿ
`^ÿ ÿ`
`b ÿ
`ÿokÿ`apÿqÿ
`Yloÿÿ r ÿÿ] ÿg
`ÿYZ[WY\Yeÿÿ
`hÿhaÿdimsismÿt]ÿ
`Yuÿ ÿm
`ÿ
`^ÿ ÿ`
`
`ÿ ÿ
` r
`^^ÿ
`ÿ ÿ ^
`r ÿ
`
`Amgen
`Exhibit 2068
`Apotex Inc., et al. v. Amgen Inc., et al.
`IPR2016-01542
`Ex. 2068-001
`
`
`
`Case:19-2171
`
`2
`
`Document:15
`
`Page:2
`
`Filed: 09/18/2019
`
`AMGEN INC. V. IANCU
`
`2) The Director of the United States Patent and
`Trademark Office shall file a docketing statement no
`more than thirty days from the issuance of this
`order.
`
`12345ÿ789:7;7ÿÿÿÿÿÿ<=>?@4AB5ÿ7CÿÿÿÿÿD2E45ÿ:ÿÿÿÿÿFGH4I5ÿJ8K7LK:J78
`
`ÿÿÿÿ
` ÿÿ ÿ
`ÿÿ
`ÿ ÿ!!ÿ!ÿÿ"ÿÿÿ
`ÿÿ#ÿ#ÿÿÿ$ÿÿÿ
`
`ÿ
`ÿÿÿÿÿ
`& 'ÿ( ÿ
`'ÿ
`ÿÿ
`ÿ
`ÿÿ
`ÿÿ
`00ÿÿ'ÿ ÿ
`)*ÿ+,-ÿ
`ÿ'ÿ ÿÿ
`
`ÿÿ
`ÿÿ
`!ÿÿ$ÿ
`ÿÿ
`
`September 18, 2019
`
`FOR THE COURT
`
`/s/ Peter R. Marksteiner
`Peter R. Marksteiner
`
`Clerk of Court
`
`EX. 2068-002
`
`Ex. 2068-002
`
`